F/m Investments LLC

Position in VRTX — Vertex Pharmaceuticals Inc / Ma

CIK 1834499 WASHINGTON, DC

Position in VRTX

as of Jun 30, 2026 · filed Aug 5, 2026 Compact

Position Value

$434,638

-$155,241 QoQ

Shares Held

875

-33.8% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#1,110

of 1,735 holders

Holding Since

Dec 2021

13 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

F/m Investments LLC holds $94,614,016 across 23 Biotechnology names. VRTX ranks #22 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	TVTX	Travere Therapeutics, Inc.	187,574	$10,656,078
2	REGN	Regeneron Pharmaceuticals, Inc.	16,783	$10,464,871
3	COGT	Cogent Biosciences, Inc.	228,688	$8,850,225
4	SYRE	Spyre Therapeutics, Inc.	92,618	$8,222,626
5	CORT	Corcept Therapeutics Inc	88,042	$7,655,251
6	MIRM	Mirum Pharmaceuticals, Inc.	51,483	$6,027,114
7	CYTK	Cytokinetics Inc	60,891	$5,187,304
8	MANE	Veradermics, Inc	35,967	$4,421,782

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$434,638	875	-33.8%	Shares	Sole	2026-08-05
2026-03-31	$589,879	1,321	-86.1%	Shares	Sole	2026-05-11
2025-12-31	$4,299,666	9,484	-2.9%	Shares	Sole	2026-02-03
2025-09-30	$3,823,972	9,764	-66.7%	Shares	Sole	2025-11-13
2025-06-30	$13,043,469	29,298	+0.0%	Shares	Sole	2025-08-13
2025-03-31	$14,201,832	29,293	-5.2%	Shares	Sole	2025-05-14
2024-12-31	$12,449,470	30,915	-27.2%	Shares	Sole	2025-02-13
2024-09-30	$19,748,692	42,463	-10.0%	Shares	Sole	2024-10-29
2024-06-30	$22,120,771	47,194	+1050.8%	Shares	Sole	2024-07-29
2024-03-31	$1,714,259	4,101	-0.7%	Shares	Sole	2024-04-23
2023-12-31	$1,680,048	4,129	-59.0%	Shares	Sole	2024-02-01
2022-03-31	$2,629,533	10,076	-0.1%	Shares	Sole	2022-08-04
2021-12-31	$2,214,666	10,085	—	Shares	Sole	2022-02-04
No filing history on record for this holder in this stock.